Esen, M., Fischer-Herr, J., Gabor, J. J., Gaile, J. M., Fleischmann, W. A., Smeenk, G. W., . . . Kremsner, P. (2024). First-in-human phase I trial to assess the safety and immunogenicity of an Orf virus-based COVID-19 vaccine booster. Vaccines, 12(11), . https://doi.org/10.3390/vaccines12111288
Chicago Style (17th ed.) CitationEsen, Meral, et al. "First-in-human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-based COVID-19 Vaccine Booster." Vaccines 12, no. 11 (2024). https://doi.org/10.3390/vaccines12111288.
MLA (9th ed.) CitationEsen, Meral, et al. "First-in-human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-based COVID-19 Vaccine Booster." Vaccines, vol. 12, no. 11, 2024, https://doi.org/10.3390/vaccines12111288.
Warning: These citations may not always be 100% accurate.